top of page
Search

Krystexxa: A Breakthrough for Gout Control

Updated: Feb 18, 2024



Addressing the Need for Advanced Treatment

If you experience more than one gout flare a year, consider advancing your treatment. Recurrent gout flares may signal that oral medications are insufficient in effectively lowering your uric acid levels and preventing the adverse impacts of uncontrolled chronic gout.


Exploring Krystexxa as a Treatment Option

Krystexxa has provided relief to gout patients for almost a decade. Research indicates that undergoing one intravenous treatment every other week for approximately six months could be all you need to regain control. Krystexxa operates differently from oral medications in lowering uric acid levels, a crucial factor in halting gout flares. Over approximately six months, it has the potential to eliminate years' worth of accumulated uric acid and Tophus in your body.


Benefits of Krystexxa Treatment

By maintaining uric acid at significantly low levels, Krystexxa helps prevent acute gout attacks, Tophus formation, renal complications, hypertension, and other damages associated with elevated uric acid. CCCHC provides Krystexxa treatments at our fully equipped infusion centers in Monterey Park, Hollywood, Alta Dena, Sherman Oaks, and Fountain Valley.


Taking Action

Consult with your doctor to determine if Krystexxa treatment is suitable for you and to receive a referral to our center for further evaluation and treatment.

 
 
 

Comments


Powered by Srini Digital

bottom of page